Diabetes technology

Implementation of Intermittently Scanned Continuous Glucose Monitoring and Changes in Hospitalizations and Health Care Costs in Insulin-Treated Type 2 Diabetes

Diabetes CarePublished Population-based longitudinal quasi-experimental cohort study

Authors' conclusion

In this real-world study, implementation of isCGM among insulin-treated adults with T2D was associated with substantial reductions in acute diabetes-related hospitalizations, shorter hospital stays, lower health care costs, and changes in cardiovascular hospitalization trends.

Study context

Population
Adults with T2D on MDI who initiated publicly funded isCGM between April 2022 and December 2023
Participants
15,413 adults
Exposure
After vs before isCGM initiation
Outcome
Hospitalizations for acute diabetes-related complications (DKA, HHS, simple hyperglycemia, hypoglycemia)
Methodological detailsinterrupted time series analyses, Poisson models, before-after comparison, Mean follow-up 22.5 ± 4.6 months before and 19.1 ± 4.4 months after isCGM initiation
  • Interrupted time series analyses
  • Poisson models
  • Before-after comparison
  • Mean follow-up 22.5 ± 4.6 months before and 19.1 ± 4.4 months after isCGM initiation

Main finding

As reported in the abstract

Diabetes-related hospitalization rate decreased (before to after isCGM initiation)

74.6 to 27.5 per 10,000 person-years

RR after vs before isCGM initiation

RR 0.37

95% CI 0.28–0.49

Observational data: associations, not effects.

Further findings

Cardiovascular hospitalizations (MI, stroke, major lower-extremity amputation)

Cardiovascular hospitalization rates remained stable (before vs after isCGM initiation)
228.8 vs. 215.8 per 10,000 person-years
RR after vs before isCGM initiation
RR 0.94 [0.84-1.06]
Interrupted time series: change in cardiovascular admission rates after isCGM initiation relative to the preintervention trend

HbA1c

Mean HbA1c decreased (before to after isCGM initiation)
8.09 to 7.65%
Mean difference
−0.44 [95% CI −0.47 to −0.42]

Length of stay

Median LOS decreased (before to after isCGM initiation)
4 (interquartile range 5) to 3 (4) days

Inpatient health care costs

Total inpatient costs decreased by
$3,806,776.90
Decrease per 10,000 person-years
-$955,186.70

Original publication

Implementation of Intermittently Scanned Continuous Glucose Monitoring and Changes in Hospitalizations and Health Care Costs in Insulin-Treated Type 2 Diabetes. Diabetes Care. Published 16 June 2026. doi:10.2337/dc26-0547

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.